MSTN and hepatocellular carcinoma: However, considering that preclinical/clinical data have reported that myostatin and sarcopenia are associated with hepatic fibrosis [11,33,42,43], patients with high serum myostatin levels could have an increased risk of developing HCC because of progressing hepatic fibrosis.